Selected Grants
Research Triangle Center of Excellence in Regulatory Science and Innovation
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028DoD: PCRP Clinical Consortium: Duke University Clinical Research Site
ResearchCo Investigator · Awarded by Department of Defense · 2007 - 2026Understanding heterogeneity and Improving the Precision of Prostate Cancer Clinical Outcomes in the Modern Era
ResearchPrincipal Investigator · Awarded by Department of Defense · 2023 - 2026Interactions of Androgen Production, Uptake and Metabolism on outcome in Castration Resistant Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2021 - 2026Defining clinically actionable subtypes of castration-resistant prostate cancer through epigenetic cell-free DNA analysis
ResearchPrincipal Investigator · Awarded by Dana-Farber Cancer Institute · 2023 - 2026Validation of predictive liquid biomarkers for patients with metastatic prostate cancer
ResearchCo Investigator · Awarded by University of Wisconsin - Madison · 2023 - 2026Sieve spline based likelihood approach for the Cox proportional hazards model with small sample size studies
ResearchCo-Principal Investigator · Awarded by National Cancer Institute · 2023 - 2026Statistical Methods and Validation Analyses for the Integration of Real-World
ResearchPrincipal Investigator · Awarded by Dana-Farber Cancer Institute · 2021 - 2025Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
ResearchPrincipal Investigator · Awarded by National Cancer Institute · 2020 - 2025Targeting neuroendocrine cells in prostate cancer with small molecule and targeted radionuclide therapies
ResearchCo Investigator · Awarded by Prostate Cancer Foundation · 2023 - 2025HERO Program, HERO Registry, HERO-HCQ Trial
Clinical TrialStatistical Investigator · Awarded by Patient-Centered Outcomes Research Institute · 2020 - 2025Surrogate Endpoints of Overall Survival in Men with Metastatic Hormone Sensitive Prostate Cancer
ResearchPrincipal Investigator · Awarded by Prostate Cancer Foundation · 2018 - 2025Targeting convergent oncogenic signaling during AR inhibition to overcome metastasis and immune evasion in prostate cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2019 - 2025PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
ResearchPrincipal Investigator · Awarded by Yale University · 2023 - 2024Development of a Clinical Genomic Model in Metastatic Castration Resistant Prostate Cancer
ResearchPrincipal Investigator · Awarded by University of Michigan · 2022 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024HOXB13 as a therapeutic target in prostate cancer
ResearchStatistician · Awarded by Prostate Cancer Foundation · 2020 - 2024Prognostic Model of Overall Survival in Bladder Cancer
ResearchPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2021 - 2023Interactions of Androgen Production, Uptake and Metabolism on outcome in CRPC
ResearchPrincipal Investigator · Awarded by University of Minnesota · 2021 - 2023PROPHECY CTC PSMA Project
ResearchPrincipal Investigator · Awarded by Epic Sciences, Inc · 2022 - 2022Precision Medicine in Platinum-treated Lethal Bladder Cancer
ResearchPrincipal Investigator · Awarded by Memorial Sloan-Kettering Cancer Center · 2017 - 2022PARPi Response Evaluation for Clinical Impact and Scientific Innovation in Oncology: The PRECISION Registry
ResearchPrincipal Investigator · Awarded by Thomas Jefferson University · 2022 - 2022Plasma Angiome and Serum Androgens as Predictors of Overall Survival in Metastatic Prostate Cancer
ResearchPrincipal Investigator · Awarded by Department of Defense · 2018 - 2022Translational Research in Surgical Oncology
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2002 - 2022Role of oncogenic phosphorylated MED1 in aggressive prostate cancer
ResearchCo Investigator · Awarded by National Institutes of Health · 2017 - 2022Health Disparity in African Americans: A Meta-analysis of Six Phase III Trials in Metastatic Castration-Resistant Prostate Cancer Men treated with Docetaxel
ResearchPrincipal Investigator · Awarded by Department of Defense · 2015 - 2021Statistical Analysis of CTC enumeration and neuroendocrine cell features in the PROPHECY trial (NCT02269982)
ResearchPrincipal Investigator · Awarded by Epic Sciences, Inc · 2020 - 2020Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC)
ResearchInvestigator · Awarded by Prostate Cancer Foundation · 2014 - 2020Serum Androgens and Survival in CRPC
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2015 - 2018Administrative Supplement to Study Mechanisms of Cancer Sensitivity and Resistance to Therapy Utilizing Samples and Information from Human Clinical Trials - CALGB 90203
ResearchPrincipal Investigator · Awarded by Brigham and Women's Hospital · 2016 - 2018Optimizing First Line Treatment for Men with Castrate Resistant Prostate Cancer
ResearchPrincipal Investigator · Awarded by Prostate Cancer Foundation · 2015 - 2018National Clinical Trials Network - Network Group Statistics and DMCs
ResearchStatistician · Awarded by Mayo Clinic · 2014 - 2017Validation of prognostic and pathway signatures in lethal prostate cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2017Developing and Validating Prognostic Models of Clinical Outcomes In Men With Castration Resistant Prostate Cancer
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2011 - 2016Expression Profiling of Renal Cell Carcinoma Utilizing Tissue from CALGB 90206
ResearchPrincipal Investigator · Awarded by Cedars Sinai Medical Center · 2012 - 2015Predictive Markers in Metastatic Renal Cancer
ResearchPrincipal Investigator · Awarded by University of California - San Francisco · 2013 - 2014Cancer and Leukemia Group B Statistical Center
ResearchStatistician · Awarded by National Institutes of Health · 1982 - 2010Telomerase RNA Transfected Dendritic Cell Vaccines
Clinical TrialStatistician · Awarded by National Institutes of Health · 2002 - 2006External Relationships
- Aveo Oncology
- Bristol-Myers Squibb (BMS)
- CG Oncology
- Janssen Oncology
- Sanofi
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.